How has been the historical performance of Dr Lal Pathlabs?

Answer:The historical performance of Dr Lal Pathlabs shows a consistent growth trajectory in net sales and profits over the years, with significant increases noted in the latest fiscal year ending March 2025.

Breakdown:
Dr Lal Pathlabs has demonstrated robust growth in net sales, rising from 1,203.40 Cr in March 2019 to 2,461.40 Cr in March 2025. The total operating income followed a similar upward trend, reaching 2,461.40 Cr in March 2025, up from 1,203.40 Cr in March 2019. Operating profit, excluding other income, also increased significantly, from 343.60 Cr in March 2020 to 695.50 Cr in March 2025. The profit before tax saw a substantial rise from 300.60 Cr in March 2019 to 624.70 Cr in March 2025, while profit after tax increased from 200.50 Cr to 492.20 Cr in the same period. The company's earnings per share (EPS) improved markedly from 23.91 in March 2019 to 58.27 in March 2025, reflecting enhanced profitability. On the balance sheet, total assets grew from 1,351.46 Cr in March 2020 to 2,630.17 Cr in March 2025, while total liabilities rose from 1,351.46 Cr to 2,630.17 Cr, indicating a proportional increase in both assets and liabilities. Cash flow from operating activities also showed improvement, increasing from 283.00 Cr in March 2020 to 568.00 Cr in March 2025, although the net cash outflow was recorded at -68.00 Cr in March 2025. Overall, Dr Lal Pathlabs has shown a strong performance with consistent growth in sales, profits, and assets over the years.